Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Neoplasia (New York, N.Y.)|March 7, 2020
TGFBR2 mediated phosphorylation of BUB1 at Ser-318 is required for transforming growth factor-β signalingShyam Nyati, Brandon S Gregg, Jiaqi Xu, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
Structure-activity relationships for a series of thiobenzamide influenza fusion inhibitors derived from 1,3,3-trimethyl-5-hydroxy-cyclohexylmethylamineKuo Long Yu, Albert F Torri, Guangxiang Luo, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2022
A dual role for CRTH2 in acute lung injuryShreya Bhattacharya, Nicholas Ristic, Avi J Cohen, et al.
Bioorganic & Medicinal Chemistry Letters|September 9, 2008
Initial SAR studies on apamin-displacing 2-aminothiazole blockers of calcium-activated small conductance potassium channelsRobert G Gentles, Katherine Grant-Young, Shuanghua Hu, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2008
Preliminary SAR studies on non-apamin-displacing 4-(aminomethylaryl)pyrrazolopyrimidine K(Ca) channel blockersRobert G Gentles, Shuanghua Hu, Yazhong Huang, et al.
Journal of Medicinal Chemistry|October 31, 2003
Identification of a potent and selective 5-HT(6) antagonist: one-step synthesis of (E)-3-(benzenesulfonyl)-2- (methylsulfanyl)pyrido[1,2-a]pyrimidin-4-ylidenamine from 2-(benzenesulfonyl)-3,3-bis(methylsulfanyl)acrylonitrileYong-Jin Wu, Huan He, Shuanghua Hu, et al.
Bioorganic & Medicinal Chemistry|February 6, 2014
Structure activity relationship studies of 3-arylsulfonyl-pyrido[1,2-a]pyrimidin-4-imines as potent 5-HT₆ antagonistsShuanghua Hu, Yazhong Huang, Yong-Jin Wu, et al.
Journal of Combinatorial Chemistry|September 12, 2006
Application of lean manufacturing concepts to drug discovery: rapid analogue library synthesisHarold N Weller, David S Nirschl, Edward W Petrillo, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2000
4-Thiazolidinones: novel inhibitors of the bacterial enzyme MurBC J Andres, J J Bronson, S V D'Andrea, et al.
ACS Medicinal Chemistry Letters|July 26, 2017
Improving Metabolic Stability with Deuterium: The Discovery of BMT-052, a Pan-genotypic HCV NS5B Polymerase InhibitorKyle Parcella, Kyle Eastman, Kap-Sun Yeung, et al.
Pageof 3